BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5481455)

  • 1. [Restructuring action of Sureptil in anxio-depressive components of involutive states].
    Carrère J
    Ann Med Psychol (Paris); 1970 Oct; 2(3):409-19. PubMed ID: 5481455
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic results with 1035 MD (apropos of 92 cases)].
    Delteil P; Douche F; Fromentin M
    Ann Med Psychol (Paris); 1971 Feb; 1(2):261-8. PubMed ID: 5577431
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of Sureptil drops in certain eye diseases].
    Le Hunsec J
    Bull Soc Ophtalmol Fr; 1972; 72(9):983-91. PubMed ID: 4666384
    [No Abstract]   [Full Text] [Related]  

  • 4. [Value of 1035 MD in psychomotor rehabilitation of slightly and moderately mentally retarded patients treated in a medicopedagogic institut].
    Parente C; Colombel JC
    Rev Neuropsychiatr Infant; 1974; 22(1):141-50. PubMed ID: 4822232
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of clinical and encephalographic action of 1035 MD in child neuropsychiatry. Apropos of 33 cases followed during a year].
    Savelli A; Rigal J
    Rev Neuropsychiatr Infant; 1974 Mar; 22(3):199-205. PubMed ID: 4841032
    [No Abstract]   [Full Text] [Related]  

  • 6. [Electro-clinical study on value of M.D. 1035 in psychiatry].
    Ey H; Barros-Fereira M; Bohard F; Natin JC
    Ann Med Psychol (Paris); 1970 Mar; 1(3):455-65. PubMed ID: 5424185
    [No Abstract]   [Full Text] [Related]  

  • 7. [Participation of a new cerebral vasodilator, 1,035 M.D. in the involutional psychoses of chronic alcoholism].
    Ducamin JP; Cron
    Encephale; 1969; 58(3):283-7. PubMed ID: 5378186
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action of 1035 M. D. in neuropsychic syndromes of vascular origin and certain involutional psychoses].
    Ey H; Bohard F
    Ann Med Psychol (Paris); 1967 Dec; 2(5):767-71. PubMed ID: 5585706
    [No Abstract]   [Full Text] [Related]  

  • 9. [Trial of 1035 MD in a population of mentally retarded subjects in medico-pedagogic institutes].
    Besançon G; Blineau-Vecchierini MF
    Rev Neuropsychiatr Infant; 1973 Sep; 21(9):565-8. PubMed ID: 4586339
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical determination of unique effect of potentiation of phenothiazine medication by nylidrin hydrochloride.
    Chu J; Doering MF; Fogel EJ
    Int J Neuropsychiatry; 1966 Feb; 2(1):53-9. PubMed ID: 5907814
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic use of a nicofuranosio-centrophenoxine association in involutive psychoses].
    Viviano M; Ceccarelli G
    Minerva Med; 1966 Nov; 57(94):3965-9. PubMed ID: 4380869
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dehydrobenzperidol (dbp) in psychiatry: clinical experiences].
    Escalar G; Saccani P
    Riv Sper Freniatr Med Leg Alien Ment; 1968 Aug; 92(4):1168-92. PubMed ID: 5738065
    [No Abstract]   [Full Text] [Related]  

  • 13. [Trial of a new coronarydilator].
    Delaage M; Benyamine R; Jouve A
    Coeur Med Interne; 1967 Oct; 6(4):479-81. PubMed ID: 5623598
    [No Abstract]   [Full Text] [Related]  

  • 14. Report on a preliminary open clinical study of mianserin (GB 94), a tetracyclic antidepressant.
    Fleischhauer J; Al-Shaltchi B; Brändli A
    Arzneimittelforschung; 1973 Dec; 23(12):1808-13. PubMed ID: 4150216
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experiences with the antidepressive agent Nortrilene].
    Melliwa H
    Hippokrates; 1965 Oct; 36(19):755-8. PubMed ID: 5863924
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prolonged clinical experimentation with MD-1036 in coronary angina].
    Routier MG
    J Sci Med Lille; 1972 Oct; 90(10):359-62. PubMed ID: 4629441
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of a cerebral vasoactive drug, 1035 MD, in 40 adolescents with severe mental retardation].
    Rossignol C
    Rev Neuropsychiatr Infant; 1972 Oct; 20(10):791-7. PubMed ID: 4650286
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of atropine in the treatment of depressive states].
    Nazarchuk AG
    Vrach Delo; 1980 Aug; (8):90-2. PubMed ID: 7415142
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of treatment of depressive states with melitracen].
    Madejska N; Mika M; Pańkow T
    Psychiatr Pol; 1967; 1(4):463-71. PubMed ID: 5595168
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prophylactic administration of lithium carbonate in affective psychoses].
    Svestka J; Náhunek K; Rodová A
    Cesk Psychiatr; 1971 Apr; 67(2):79-86. PubMed ID: 5554019
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.